Infectious Diseases and Vaccines

Home / Infectious Diseases and Vaccines

Strengthening Global Health Through Infectious Disease Innovation

Delivering trusted pathways for vaccines and anti‑infective therapies with speed, resilience, and scientific credibility

Emerging infectious diseases, antimicrobial resistance, and evolving vaccine technologies demand agile development strategies, rapid execution, and strong regulatory expertise. Novaspire supports sponsors developing vaccines and anti-infective therapies through integrated scientific, clinical, and regulatory solutions that accelerate global development , ensuring that innovation reaches patients and communities faster.

Our Distinctive Expertise

Rapid clinical Trial activation

Rapid frameworks for outbreak‑driven studies and accelerated vaccine programs.

Global Regulatory Strategy

Skilled in global regulatory (CDSCO, FDA, EMA, WHO, etc) pathways, ensuring submissions meet international standards.

Vaccine Development Expertise

End‑to‑end consulting from early formulation through Phase III, including dossier preparation and monitoring.

Safety & Data Integrity

Systems that protect patient safety and reinforce sponsor credibility.

Hallmarks of Our Pharmacovigilance Solutions

Our PV solutions are meticulously designed to meet global regulatory standards, ensuring seamless compliance across regions.

From specific activities to complete PV system setup, we customize our services to align with client needs and product portfolios.

We focus on assessing and enhancing the risk-benefit profiles of products, safeguarding patient safety while maximizing market potential.

Our solutions are adaptable, supporting local requirements and expanding effortlessly to meet global pharmacovigilance demands.

By leveraging advanced tools and analytics, we streamline processes like case management, signal detection, and reporting for optimal efficiency.

From ICSR case processing to aggregate reporting and post-authorization studies, we provide comprehensive support throughout the product lifecycle.

Our team of seasoned PV professionals, including QPPVs and medics, ensures robust safety monitoring and insightful decision-making.

Continuous surveillance identifies potential safety issues early, allowing timely action to mitigate risks.

We prioritize clarity and transparency in all interactions, keeping clients informed and confident in every aspect of pharmacovigilance management.

Talk to Our Experts

Lorem Ipsum is simply dummy text of the printing

Why Choose Us

Agility in Outbreaks

Rapid mobilization of sites and frameworks to respond to urgent infectious disease scenarios.

Scientific & Clinical Expertise

Integrated support across the entire gastroenterology development lifecycle.

Global Development Capabilities

Access to experienced investigators, specialized GI sites, and regulatory expertise.

Patient-Centric Trial Design

Strategies that improve recruitment, retention, and study quality.

Pharmacovigilance Related Blogs

Therapeutic Expertise

Viral infections: influenza, hepatitis
Bacterial infections: tuberculosis, pneumonia, resistant pathogens
Parasitic diseases: malaria, neglected tropical diseases
Preventive and therapeutic vaccines across multiple indications

Speak to an Expert

Talk to our experts today to streamline your regulatory journey.